Lancôme Absolue Longevity MD Reset The Cream Review

Urolithin A had a good decade before it reached a face cream. The molecule is what your gut bacteria make from the ellagitannins in pomegranates, and a Swiss company called Timeline turned a purified version into Mitopure, a supplement with a respectable clinical record for improving mitochondrial function in ageing muscle. That is real science, published in real journals, and it is the reason the word longevity is on this jar. Lancôme licensed the ingredient, unveiled the line at a dermatology conference in March 2026, and launched it in April with a doctors' advisory board and language about choosing your skin's biological age. Reset The Cream is the top tier, for skin where the signs are already showing. The question a skeptic should ask is not whether Mitopure works, because for muscles it seems to, but whether a molecule that reaches mitochondria through the bloodstream does anything useful when it is eighteenth on the ingredient list of a rich cream sitting on the surface of the face. The honest answer is that nobody outside the supplier has shown that it does.

Here is what the evidence actually contains. Urolithin A protects cultured skin fibroblasts from UVA damage and switches on mitophagy in the dish, which is interesting biology. A preprint from Timeline's own scientists reports small randomised trials of one percent topical urolithin A reducing wrinkles and UV redness against untreated skin, which is encouraging and also unreviewed, supplier-funded and not about this product. Lancôme's own claims for the cream, fifty-five percent more bounce four hours after application and fifteen percent faster surface renewal over three weeks, are measurements any rich, gently exfoliating moisturiser would post, and the four-year drop in visible biological age is a score the brand defines from photographs rather than anything a biologist would call a clock. None of that makes the cream bad. It makes the longevity framing a story that the formula does not need and cannot yet support.

Because the formula, judged as a cream rather than as a manifesto, is genuinely good. Rhamnose sits third, above the oils, which is a bold placement for a sugar L'Oréal has spent years studying for its effect on the dermal-epidermal junction and collagen synthesis. Niacinamide is fifth, high enough to be doing real barrier and tone work. Further down come Pro-Xylane with taurine, the pairing Lancôme has built its Absolue creams on for two decades, the Matrixyl 3000 peptide duo, ginkgo, adenosine, and a gentle exfoliating pair of capryloyl salicylic acid and plain salicylic acid that explains both the renewal claim and the faint tingle people report on their first few nights. Around all of that is a base of apricot kernel oil, shea, petrolatum, beeswax and fatty alcohols, which is why the cream feels the way a $155 cream is supposed to feel: dense in the jar, melting on contact, cushioned and plump on the skin within seconds. The four-hour bounce claim is describing that base doing its job.

The experience, for the right skin, is a pleasure. Mature, dry skin gets a night cream that seals a serum in, softens overnight and leaves the surface smoother and more even by the third week as the LHA works. The rose-and-powder fragrance is the house scent and it is not subtle; people who love Lancôme love it, and people with reactive skin should note that fragrance, denatured alcohol and two salicylates in one cream is a combination that rosacea and eczema will not thank them for. Daytime is the other limit. Under makeup in a warm office the shea and petrolatum base settles into lines and slides, which is the single most common complaint in an otherwise glowing review pool, and most owners end up using it at night with something lighter in the morning.

That review pool deserves a note. Five months after launch, Ulta lists more than sixteen hundred reviews at 4.7 stars, which is a remarkable number for a $155 cream in that time and reads as the brand's early-reviewer programme and syndicated site reviews rather than sixteen hundred spontaneous customers. The praise is consistent and probably accurate as far as it goes: lovely texture, plumper skin, softer lines. The complaints are just as consistent: too rich by day, too expensive, too perfumed, and the longevity claims feel like marketing. Nobody in either camp has any way of knowing whether the urolithin A did anything.

Which brings us to the money. At $155 for 50ml, with a refill pod that brings repeat purchases down somewhat, this is priced as a prestige cream and it delivers the prestige experience. What it does not deliver is any evidence that it outperforms Lancôme's own Absolue Rich Cream, which shares much of the architecture, or a well-chosen niacinamide-and-peptide cream at a third of the price, because the ingredient that justifies the premium has not been independently shown to do anything topically at this dose. L'Oréal's research depth is real and I would trust the rhamnose and Pro-Xylane work more than I trust most brand science, but that work was already in the older creams.

Strip away the biology lesson and the buying advice is plain. If you have mature, dry, resilient skin, you enjoy a rich fragranced night cream, and $155 is a comfortable indulgence, this is a very well-made one with a credible core and a cushioned texture that earns its place on a dresser. Buy the refill after the first jar. If you are buying for the urolithin A and the promise of turning back a biological clock, you are paying for a licensing deal and a beautifully told story, and the skeptics in the reviews who called the longevity language marketing were not being unfair.